RU2002129171A - RECOMBINANT ATTENUATED STRAIN OF BACTERIA SALMONELLA ENTERIDITIS E-23 / PGEX-2T-TBI AS A CANDIDATE FOR CONSTRUCTION OF A LIVING Vaccine Against Human Immunodeficiency Virus - Google Patents

RECOMBINANT ATTENUATED STRAIN OF BACTERIA SALMONELLA ENTERIDITIS E-23 / PGEX-2T-TBI AS A CANDIDATE FOR CONSTRUCTION OF A LIVING Vaccine Against Human Immunodeficiency Virus

Info

Publication number
RU2002129171A
RU2002129171A RU2002129171/13A RU2002129171A RU2002129171A RU 2002129171 A RU2002129171 A RU 2002129171A RU 2002129171/13 A RU2002129171/13 A RU 2002129171/13A RU 2002129171 A RU2002129171 A RU 2002129171A RU 2002129171 A RU2002129171 A RU 2002129171A
Authority
RU
Russia
Prior art keywords
tbi
pgex
candidate
construction
immunodeficiency virus
Prior art date
Application number
RU2002129171/13A
Other languages
Russian (ru)
Other versions
RU2237089C2 (en
Inventor
Лариса Ивановна Карпенко
Надежда Александровна Некрасова
Георгий Михайлович Игнатьев
Александр Алексеевич Ильичев
Марина Николаевна Бойченко
Анатолий Андреевич Воробьев
Original Assignee
Государственный научный центр вирусологии и биотехнологии "Вектор"
Filing date
Publication date
Application filed by Государственный научный центр вирусологии и биотехнологии "Вектор" filed Critical Государственный научный центр вирусологии и биотехнологии "Вектор"
Priority to RU2002129171/13A priority Critical patent/RU2237089C2/en
Priority claimed from RU2002129171/13A external-priority patent/RU2237089C2/en
Publication of RU2002129171A publication Critical patent/RU2002129171A/en
Application granted granted Critical
Publication of RU2237089C2 publication Critical patent/RU2237089C2/en

Links

Claims (1)

Рекомбинантный аттенуированный штамм бактерий Salmonella enteriditis E-23/pGEX-2T-TBI, депонированный в коллекции НИИ ККМ ГНЦ ВБ "Вектор" под номером В-884, - продуцент искусственного белка-иммуногена TBI, содержащего эпитопы нескольких белков ВИЧ-1.The recombinant attenuated bacterial strain Salmonella enteriditis E-23 / pGEX-2T-TBI, deposited in the collection of the Research Institute of KKM SSC VB "Vector" under the number B-884, is a producer of the artificial TBI immunogen protein containing epitopes of several HIV-1 proteins.
RU2002129171/13A 2002-10-31 2002-10-31 Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus RU2237089C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002129171/13A RU2237089C2 (en) 2002-10-31 2002-10-31 Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002129171/13A RU2237089C2 (en) 2002-10-31 2002-10-31 Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus

Publications (2)

Publication Number Publication Date
RU2002129171A true RU2002129171A (en) 2004-07-20
RU2237089C2 RU2237089C2 (en) 2004-09-27

Family

ID=33433118

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002129171/13A RU2237089C2 (en) 2002-10-31 2002-10-31 Recombinant attenuated strain of bacterium salmonella enteriditis e-23/pgex-2t-tbi as candidate for construction of live vaccine against human immunodeficiency virus

Country Status (1)

Country Link
RU (1) RU2237089C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010108682A1 (en) * 2009-03-27 2010-09-30 Eidgenoessische Technische Hochschule Zürich Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof

Similar Documents

Publication Publication Date Title
Bull et al. The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine
ES2190799T5 (en) PEPTIDIC IMMUNOGENS FOR VACCINATION AND TREATMENT AGAINST ALLERGY.
Reynolds et al. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.
CY1117643T1 (en) NANCY VACCINE COMPOSITIONS INCLUDING ANTIGON COMBINATION
PE20040554A1 (en) VACCINES INVOLVING FUSION PROTEINS
ATE376559T1 (en) METHODS OF PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
NO20002413L (en) Antibodies to Moraxella proteins and their use, as well as sets for the detection of antigen and pharmaceutical preparations containing antibodies
DE60043856D1 (en) IMPROVEMENTS IN OR RELATED TO IMMUNE RESOLUTIONS AGAINST HIV
ATE162723T1 (en) THE INDUCTION OF THE ANTIBODIES RESPONSE AGAINST OWN PROTEINS WITH THE HELP OF FOREIGN T-CELL EPITOPES
TR200102729T2 (en) Protein for blocking platelet adhesion
RU2013128866A (en) Immunogenic peptides for use in the prophylaxis and / or treatment of infectious diseases, autoimmune diseases, the immune response to allogeneic FACTORS, allergic diseases, tumor, transplant rejection and immune responses against viral vectors USED FOR GENE THERAPY OR GENE VACCINATION
Oftung et al. Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells.
RU2010129538A (en) NGF CONJUGATES AND THEIR APPLICATION
ATE238065T1 (en) PEPTIDES FOR USE IN VACCINATION AND STIMULATION OF ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUS
Rzepczyk et al. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.
DK0494294T3 (en) Bacterial stress proteins
DK0996726T3 (en) T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and use thereof
Joshi et al. Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology
DE69508382D1 (en) PEPTOMERS WITH INCREASED IMMUNOGENICITY
RU2002129171A (en) RECOMBINANT ATTENUATED STRAIN OF BACTERIA SALMONELLA ENTERIDITIS E-23 / PGEX-2T-TBI AS A CANDIDATE FOR CONSTRUCTION OF A LIVING Vaccine Against Human Immunodeficiency Virus
US5609872A (en) Peptides comprising a protective epitope from blood stages of plasmodium falciparum
CA2527795A1 (en) Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
ES2331321T3 (en) NEW CD40 MULTIMERICAL LINKS, ITS PREPARATION PROCEDURE AND ITS USE FOR THE PREPARATION OF MEDICINES.
Siddique et al. Antibodies to sequences in a non-repeat region of Plasmodium falciparum antigen Pf155/RESA inhibit either cytoadherence or parasite growth in vitro
Bomford et al. Antibodies to interleukin-1 raised with synthetic peptides: identification of external sites and analysis of interleukin-1 synthesis in stimulated human peripheral blood monocytes.